Marian Case

1.4k total citations
26 papers, 856 citations indexed

About

Marian Case is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, Marian Case has authored 26 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 14 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Marian Case's work include Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Marian Case is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (10 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Marian Case collaborates with scholars based in United Kingdom, Germany and United States. Marian Case's co-authors include Andrew G. Hall, Nick Bown, Julie Irving, Christine J. Harrison, Lynne Minto, Julie Irving, Josef Vormoor, Elizabeth Matheson, Simon Bailey and Linda Hogarth and has published in prestigious journals such as Blood, Cancer Research and Infection and Immunity.

In The Last Decade

Marian Case

26 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marian Case United Kingdom 15 512 374 313 168 140 26 856
Charlotte Guldborg Nyvold Denmark 18 288 0.6× 529 1.4× 364 1.2× 96 0.6× 167 1.2× 73 982
Stefanie Groeneveld‐Krentz Germany 11 391 0.8× 272 0.7× 155 0.5× 130 0.8× 134 1.0× 15 587
Shuhong Shen China 15 175 0.3× 226 0.6× 467 1.5× 87 0.5× 105 0.8× 59 903
Richard Schabath Germany 10 306 0.6× 363 1.0× 134 0.4× 43 0.3× 115 0.8× 17 562
Quentin Lécrevisse Spain 16 114 0.2× 397 1.1× 385 1.2× 22 0.1× 224 1.6× 35 933
Yoo‐Jin Kim South Korea 16 187 0.4× 364 1.0× 98 0.3× 40 0.2× 151 1.1× 49 617
ED Ball United States 22 282 0.6× 911 2.4× 548 1.8× 18 0.1× 325 2.3× 47 1.5k
Thai M. Cao United States 17 92 0.2× 379 1.0× 164 0.5× 25 0.1× 296 2.1× 48 866
Lynn Heltemes-Harris United States 15 130 0.3× 123 0.3× 202 0.6× 27 0.2× 179 1.3× 23 695
Sandra Quijano Colombia 13 118 0.2× 143 0.4× 148 0.5× 35 0.2× 149 1.1× 40 661

Countries citing papers authored by Marian Case

Since Specialization
Citations

This map shows the geographic impact of Marian Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marian Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marian Case more than expected).

Fields of papers citing papers by Marian Case

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marian Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marian Case. The network helps show where Marian Case may publish in the future.

Co-authorship network of co-authors of Marian Case

This figure shows the co-authorship network connecting the top 25 collaborators of Marian Case. A scholar is included among the top collaborators of Marian Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marian Case. Marian Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mašić, Dino, Marian Case, David McDonald, et al.. (2022). Hyperactive CREB subpopulations increase during therapy in pediatric B-lineage acute lymphoblastic leukemia. Haematologica. 108(4). 981–992. 6 indexed citations
2.
Sinclair, Paul, Sarra Ryan, Matthew Bashton, et al.. (2019). SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain. Leukemia. 33(8). 1881–1894. 22 indexed citations
3.
Matheson, Elizabeth, Huw D. Thomas, Marian Case, et al.. (2019). Glucocorticoids and selumetinib are highly synergistic in RAS pathway-mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica. 104(9). 1804–1811. 21 indexed citations
4.
Doan, Minh, Marian Case, Dino Mašić, et al.. (2017). Label-Free Analyses of Minimal Residual Disease in ALL Using Deep Learning and Imaging Flow Cytometry. Blood. 130. 1437–1437. 2 indexed citations
5.
Pal, Deepali, Marian Case, Julie Irving, et al.. (2016). BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance. Klinische Pädiatrie. 228(3). 2 indexed citations
6.
Irving, Julie, Elizabeth Matheson, Lynne Minto, et al.. (2014). Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood. 124(23). 3420–3430. 163 indexed citations
7.
Irving, Julie, Elizabeth Matheson, Lynne Minto, et al.. (2013). RAS Pathway Mutations Are Highly Prevalent In Relapsed Childhood Acute Lymphoblastic Leukaemia, Are Frequently Relapse-Drivers and Confer Sensitivity To MEK Inhibition. Blood. 122(21). 823–823. 2 indexed citations
8.
Nicholson, Lindsay, Thomas G. Knight, Elizabeth Matheson, et al.. (2011). Casitas B lymphoma mutations in childhood acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 51(3). 250–256. 12 indexed citations
10.
12.
Case, Marian, Elizabeth Matheson, Lynne Minto, et al.. (2008). Mutation of Genes Affecting the RAS Pathway Is Common in Childhood Acute Lymphoblastic Leukemia. Cancer Research. 68(16). 6803–6809. 90 indexed citations
13.
Hogarth, Linda, Christopher P.F. Redfern, Jens M. Teodoridis, et al.. (2008). The effect of thiopurine drugs on DNA methylation in relation to TPMT expression. Biochemical Pharmacology. 76(8). 1024–1035. 27 indexed citations
14.
Parker, Helen, Qian An, Kerry E. Barber, et al.. (2008). The complex genomic profile of ETV6‐RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1. Genes Chromosomes and Cancer. 47(12). 1118–1125. 43 indexed citations
15.
Bown, Nick, et al.. (2007). High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genetics and Cytogenetics. 172(2). 127–138. 29 indexed citations
16.
Case, Marian, et al.. (2006). Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia. British Journal of Haematology. 132(6). 740–742. 20 indexed citations
17.
Matheson, Elizabeth, Linda Hogarth, Marian Case, Julie Irving, & Andrew G. Hall. (2006). DHFR and MSH3 co-amplification in childhood acute lymphoblastic leukaemia, in vitro and in vivo. Carcinogenesis. 28(6). 1341–1346. 10 indexed citations
18.
Anderson, Rosaleen J., Donald Cairns, Marian Case, et al.. (2006). Design, Synthesis and Initial In Vitro Evaluation of Novel Prodrugs for the Treatment of Cystinosis. Letters in Drug Design & Discovery. 3(5). 336–345. 7 indexed citations
19.
Case, Marian, Alastair D. Burt, Jane Hughes, et al.. (1999). Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol. Journal of Immunological Methods. 223(1). 93–106. 14 indexed citations
20.
Case, Marian, Glenn N. Major, Margaret F. Bassendine, & Alastair D. Burt. (1997). The universality of immuno-PCR for ultrasensitive antigen detection. Biochemical Society Transactions. 25(2). 374S–374S. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026